KALA BIO News

HC Wainwright & Co. : The Kala Bio (KALA.US) rating was maintained, adjusted from buy to buy rating, and the target price was adjusted from $21.00 to $18.00.

Zhitong FinanceMay 17 22:50

Kala Bio Analyst Ratings

BenzingaMay 17 22:44

HC Wainwright & Co. Maintains Buy on Kala Bio, Lowers Price Target to $18

BenzingaMay 17 22:46

Kala Bio Analyst Ratings

BenzingaApr 2 23:46

Kala Bio Analyst Ratings

BenzingaApr 1 21:21

Oppenheimer Reiterates Outperform on Kala Bio, Maintains $15 Price Target

BenzingaApr 1 21:23

HC Wainwright & Co. Maintains Buy on Kala Bio, Lowers Price Target to $22

BenzingaNov 17, 2023 19:49

Kala Bio Analyst Ratings

BenzingaNov 17, 2023 19:48

HC Wainwright & Co. Reiterates Buy on Kala Bio, Maintains $24 Price Target

BenzingaAug 12, 2023 01:11

Kala Bio Analyst Ratings

BenzingaAug 12, 2023 01:10

Wedbush Cuts Kala Pharmaceuticals' Price Target to $39 From $42, Maintains Outperform Rating

MT NewswiresAug 5, 2023 03:51

Kala Pharmaceuticals (KALA) Gets a Buy From Wedbush

TipRanksMay 11, 2023 18:45

HC Wainwright & Co. Reiterates Buy on Kala Pharmaceuticals, Raises Price Target to $24

BenzingaMay 10, 2023 18:44

H.C. Wainwright Sticks to Its Buy Rating for Kala Pharmaceuticals (KALA)

TipRanksMay 10, 2023 18:25

HC Wainwright & Co. Reiterates Buy on Kala Pharmaceuticals, Maintains $22 Price Target

BenzingaMay 1, 2023 18:25

Kala Pharmaceuticals (KALA) Gets a Buy From H.C. Wainwright

TipRanksMay 1, 2023 18:21

HC Wainwright & Co. Adjusts Price Target on Kala Pharmaceuticals to $22 From $20, Keeps Buy Rating

MT NewswiresApr 12, 2023 22:01

HC Wainwright & Co. Maintains Buy on Kala Pharmaceuticals, Raises Price Target to $22

BenzingaApr 12, 2023 21:55

HC Wainwright & Co. Reiterates Buy on Kala Pharmaceuticals, Maintains $20 Price Target

BenzingaMar 27, 2023 23:11

HC Wainwright Adjusts Price Target on Kala Pharmaceuticals to $20 From $12, Keeps Buy Rating

MT NewswiresMar 6, 2023 20:38